Impact on direct and indirect costs of switching patients with inflammatory bowel disease from intravenous to subcutaneous infliximab (CT-P13)

por Carbery, Isabel, Burdge, Gemma, Clark, Tanya, Broglio, Giacomo, Greer, Dan, Alakkari, Alaa, Selinger, Christian Philipp
Publicado 2023

A Case of Primary Gastric Melanoma Exhibiting a Rare BRAF V600R Mutation

por Callaghan, Grainne M., Kelleher, Fergal C., Ridgway, Paul F., Crowther, Stephen, Alakkari, Alaa, Ryan, Barbara M.
Publicado 2018